The mean differences in A1c and body weight between IDegLira and basalbolus therapy and IDeglira and basal glargine were 0.3% and 6.89 kg and 0.65% and 4.04 kg respectively
"We can't commit to a specific date, but we're hoping it's going to be very soon, and we've already got patients registering their interest with us now." At the same time, he cautions that the pill will not be available to everyone
Bottom Line: People on GLP-1s Should Be Monitored for Health Changes Experts say the findings should not discourage appropriate use of GLP-1 medications, which provide significant benefits for many people with diabetes and obesity, including improvements in heart health, kidney function, and liver disease
Vzquez-Meza H, Vilchis-Landeros MM, Vzquez-Carrada M, Uribe-Ramrez D, Matuz-Mares D
Beyond weight loss, this treatment supports long-term metabolic health, energy, and confidence
CJC-1295 What is the main difference between BPC-157 and CJC-1295